These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7590659)

  • 1. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.
    Tajiri K; Miyakawa H; Izumi N; Marumo F; Sato C
    Hepatology; 1995 Nov; 22(5):1430-5. PubMed ID: 7590659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans.
    Kanno K; Hirata Y; Emori T; Ohta K; Eguchi S; Imai T; Marumo F
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):619-25. PubMed ID: 1327594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
    Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pressor, renal and endocrine effects of systemic infusion of L-arginine in hypertensive patients].
    Dell'Omo G; Catapano G; Ebel M; Gazzano A; Ducci M; Del Chicca M; Clerico A; Pedrinelli R
    Ann Ital Med Int; 1995; 10(2):107-12. PubMed ID: 7619649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
    Woitas RP; Heller J; Stoffel-Wagner B; Spengler U; Sauerbruch T
    Hepatology; 1997 Oct; 26(4):858-64. PubMed ID: 9328305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
    Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites.
    Bosch-Marcé M; Morales-Ruiz M; Jiménez W; Bordas N; Solé M; Ros J; Deulofeu R; Arroyo V; Rivera F; Rodés J
    Hepatology; 1998 May; 27(5):1191-9. PubMed ID: 9581670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
    Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
    Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation.
    Laffi G; Foschi M; Masini E; Simoni A; Mugnai L; La Villa G; Barletta G; Mannaioni PF; Gentilini P
    Hepatology; 1995 Dec; 22(6):1666-73. PubMed ID: 7489972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis.
    Niederberger M; Ginès P; Tsai P; Martin PY; Morris K; Weigert A; McMurtry I; Schrier RW
    Hepatology; 1995 Jun; 21(6):1625-31. PubMed ID: 7768508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
    Jespersen B; Jensen L; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natriuresis and blood pressure in patients with chronic renal failure following L-arginine infusion].
    Arai J; Kubota K; Hara Y; Tsuchiya K; Naruse K; Naruse M; Nihei H; Sugino N
    Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):11-5. PubMed ID: 10737008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.